0001209191-21-009357.txt : 20210210 0001209191-21-009357.hdr.sgml : 20210210 20210210175223 ACCESSION NUMBER: 0001209191-21-009357 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210208 FILED AS OF DATE: 20210210 DATE AS OF CHANGE: 20210210 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Countouriotis Athena CENTRAL INDEX KEY: 0001571469 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38871 FILM NUMBER: 21615422 MAIL ADDRESS: STREET 1: C/O AMBIT BIOSCIENCES CORPORATION STREET 2: 11080 ROSELLE STREET CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Turning Point Therapeutics, Inc. CENTRAL INDEX KEY: 0001595893 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 463826166 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 10628 SCIENCE CENTER DRIVE, SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-926-5251 MAIL ADDRESS: STREET 1: 10628 SCIENCE CENTER DRIVE, SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92121 FORMER COMPANY: FORMER CONFORMED NAME: TP Therapeutics, Inc. DATE OF NAME CHANGE: 20181018 FORMER COMPANY: FORMER CONFORMED NAME: TP Therapeutics, INC DATE OF NAME CHANGE: 20140106 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-02-08 0 0001595893 Turning Point Therapeutics, Inc. TPTX 0001571469 Countouriotis Athena C/O TURNING POINT THERAPEUTICS, INC. 10628 SCIENCE CENTER DRIVE, STE. 200 SAN DIEGO CA 92121 1 1 0 0 President & CEO Common Stock 2021-02-08 4 A 0 22617 0.00 A 50195 D Stock Option (right to buy) 140.01 2021-02-08 4 A 0 101775 0.00 A 2031-02-07 Common Stock 101775 101775 D Represents restricted stock unit award granted under the Issuer's 2019 Equity Incentive Plan. Includes 369 shares acquired by the Reporting Person on June 10, 2020 pursuant to the Issuer's Employee Stock Purchase Plan (the "ESPP") and 337 shares acquired on December 10, 2020 pursuant the ESPP. 1/48th of the shares vest monthly following February 8, 2021. /s/ Annette North, Attorney-in-Fact 2021-02-10